1. Home
  2. ATYR vs MIND Comparison

ATYR vs MIND Comparison

Compare ATYR & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • MIND
  • Stock Information
  • Founded
  • ATYR 2005
  • MIND 1987
  • Country
  • ATYR United States
  • MIND United States
  • Employees
  • ATYR N/A
  • MIND N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • MIND Industrial Machinery/Components
  • Sector
  • ATYR Health Care
  • MIND Industrials
  • Exchange
  • ATYR Nasdaq
  • MIND Nasdaq
  • Market Cap
  • ATYR 77.1M
  • MIND 67.5M
  • IPO Year
  • ATYR 2015
  • MIND 1994
  • Fundamental
  • Price
  • ATYR $0.71
  • MIND $10.45
  • Analyst Decision
  • ATYR Buy
  • MIND
  • Analyst Count
  • ATYR 6
  • MIND 0
  • Target Price
  • ATYR $8.75
  • MIND N/A
  • AVG Volume (30 Days)
  • ATYR 3.8M
  • MIND 341.1K
  • Earning Date
  • ATYR 11-06-2025
  • MIND 12-09-2025
  • Dividend Yield
  • ATYR N/A
  • MIND N/A
  • EPS Growth
  • ATYR N/A
  • MIND N/A
  • EPS
  • ATYR N/A
  • MIND 2.54
  • Revenue
  • ATYR $190,000.00
  • MIND $48,612,000.00
  • Revenue This Year
  • ATYR $420.85
  • MIND $2.33
  • Revenue Next Year
  • ATYR $1,513.40
  • MIND N/A
  • P/E Ratio
  • ATYR N/A
  • MIND $4.36
  • Revenue Growth
  • ATYR N/A
  • MIND 27.70
  • 52 Week Low
  • ATYR $0.68
  • MIND $3.75
  • 52 Week High
  • ATYR $7.29
  • MIND $14.50
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 29.54
  • MIND 44.00
  • Support Level
  • ATYR $0.68
  • MIND $13.09
  • Resistance Level
  • ATYR $0.77
  • MIND $14.50
  • Average True Range (ATR)
  • ATYR 0.06
  • MIND 1.11
  • MACD
  • ATYR 0.03
  • MIND -0.25
  • Stochastic Oscillator
  • ATYR 11.19
  • MIND 6.49

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.

Share on Social Networks: